Darzalex Faspro's supply and availability remain unaffected, and no new clinical studies were requested by the FDA.

As HHS Secretary, Kennedy cut nearly $500 million in funding for mRNA vaccine research. While he says that the decision was made after looking at the science, health experts have heavily criticized ...

Rob Abbott, CEO, ISPOR, highlights how uniting regulators, payers, and academic leaders worldwide can accelerate access to innovative treatments and strengthen evidence-based healthcare.

Pharm Exec unveils its new slate of rising leaders in the biopharma industry—profiling the stories of five executives ...